Home » Topics » Regulatory » Patents

Patents
RSS

Researchers at Compugen present new fusion proteins

Nov. 12, 2012

Pfizer divulges new lpxC inhibitors for bacterial infections

Nov. 9, 2012

Merck & Co. prepares novel agents for diabetes and obesity

Nov. 9, 2012

Scientists at Vertex Pharmaceuticals patent new protein kinase inhibitors

Nov. 9, 2012

Sloan-Kettering Institute for Cancer Research patents new HSP 90 inhibitors

Nov. 9, 2012

Laboratoire Biodim discloses new agents for HIV infection

Nov. 9, 2012

Merck & Co. presents novel BACE inhibitors

Nov. 9, 2012

New nNOS inhibitors presented by Northwestern University

Nov. 8, 2012

Pfizer patents novel Trk inhibitors for the treatment of pain

Nov. 8, 2012

Novel gamma-secretase inhibitors disclosed by Merck & Co.

Nov. 8, 2012

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...